Moreover, we found that TGFb ligand treatment led to an increase in SNCA expression in our PD cell model, and aSyn-overexpression led to an up-regulation of TGFB1, TGFB2, SMAD2, and SMAD3 in LUHMES cells. This evidence concerns the gene TGFB2 and Parkinson disease.